Just went back over some older presentations........compelling stuff now we have some hard data to hang our hats on so to speak. And with the FDA looking to 'fast track' and provide incentives for new entrants along with an increase the exclusivity period this data re BTX1801 is a very significant and exciting development.............on so many levels.
This presentation well worth a re-read imo.
https://www.asx.com.au/asxpdf/20180702/pdf/43w66mzd0sdhcp.pdf
A couple of selected slides from it:
Ann: BTX 1801 Kills Superbugs Without Resistance World-First, page-449
-
- There are more pages in this discussion • 174 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
-0.005(1.18%) |
Mkt cap ! $761.8M | |||
| Open | High | Low | Value | Volume |
| 43.0¢ | 44.5¢ | 41.5¢ | $2.435M | 5.697M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 819538 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 29052 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |